Scott Piper, MD
Family Medicine · Cedar Rapids, IANPI 1194712976
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 183 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 40.7% of the total. Reporting peaked in 2023 at $862 and has fallen 72.1% since, to $241 in 2024. Among family medicine clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $14.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Pfizer$396
- Novo Nordisk$211
- AstraZeneca$171
- Amgen$168
- Axsome Therapeutics, Inc.$99
- plus $545 from 12 others
What the payments were for
- Food & beverage$2,675100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 89 | $1,092 |
| Pfizer | 23 | $396 |
| Novo Nordisk | 12 | $211 |
| AstraZeneca | 12 | $171 |
| Amgen | 10 | $168 |
| Axsome Therapeutics, Inc. | 6 | $99 |
| Lilly USA, LLC | 5 | $93 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $86 |
| Exact Sciences | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $69 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Almatica Pharma LLC | 2 | $34 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| GSK | 1 | $14 |
How this compares
$2,682 in reported general payments places this provider in the 90th percentile of 1,357 family medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 26 | $344 |
| Levothyroxine Sodium | 19 | $165 |
| Atorvastatin Calcium | 23 | $125 |
| Sumatriptan Succinate | 14 | $96 |
| Trazodone Hcl | 11 | $65 |
| Lisinopril | 19 | $56 |
| Metoprolol Succinate | 12 | $51 |
| Metformin Hcl | 14 | $46 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 14 | $39 |
| Amlodipine Besylate | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Cedar Rapids
- Casey BoylesCedar Rapids$8K
- Ann SoenenCedar Rapids$8K
- Jason BoothCedar Rapids$7K
- Kirk PetersonHuxley$576K
- Nicholas GoetschWaterloo$525K
- Stephen HarrisonClinton$249K
- Thomas RossDes Moines$170K
- Yogesh ShahDes Moines$159K
- Leslie George PaulsenMuscatine$136K
- Dylan LoweDes Moines$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.